查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2006368

NGS樣品製備市場：2026-2032年全球市場預測（按產品類型、技術、工作流程階段、應用和最終用戶分類）

NGS Sample Preparation Market by Product Type, Technology, Workflow Step, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，NGS 樣品製備市場價值將達到 32.4 億美元，到 2026 年將成長至 37.2 億美元，到 2032 年將達到 94.5 億美元，年複合成長率為 16.52%。

主要市場統計數據
基準年 2025 32.4億美元
預計年份：2026年 37.2億美元
預測年份 2032 94.5億美元
複合年成長率 (%) 16.52%

本文揭示了為什麼針對次世代定序的最佳化樣品製備是一項策略能力，能夠提升數據品質、工作流程效率和競爭優勢。

次世代定序的樣品製備是決定資料完整性、處理速度以及下游分析準確性的關鍵環節，適用於科研、臨床和工業領域。過去十年，試劑、工作流程和自動化技術的不斷改進，持續縮短了定序週期，並拓展了應用範圍，從標靶定序擴展到全基因組和元基因組組分析。在此背景下，樣品製備不再只是常規的上游工程，而是一項策略性能力，對整個定序專案的通量、可重複性和成本效益有顯著影響。

本次演講將說明技術、營運和應用主導的變革，這些變革正在重塑整個實驗室的樣品製備工作流程和供應商優先事項。

在技​​術創新、終端用戶需求變化和監管要求不斷調整的驅動下，次世代定序的樣本製備領域正經歷著許多變革。酵素工程和化學的進步使得即使在低起始量、劣化或儲存的樣本條件下，也能可靠地進行片段化和樣品製備。同時，微流體技術和基於液滴的方法為常規工作流程帶來了小型化和平行化。除了這些技術變革之外，人們也越來越關注自動化和封閉式系統解決方案，這些方案能夠減少操作人員的差異並縮短結果獲取時間，尤其是在旨在提高診斷通量的臨床檢查室中。

本分析探討了 2025 年美國關稅變化和貿易政策調整如何提高了供應鏈摩擦、採購複雜性和區域韌性的優先順序。

2025年美國關稅措施和貿易政策調整的疊加效應，為全球樣品製備試劑、塑膠和設備的供應鏈帶來了新的摩擦。進口關稅的提高和更嚴格的分類要求增加了部分硬體組件和特殊耗材的採購成本，迫使採購團隊必須尋求供應商多元化、重新審視庫存策略並重新考慮合約條款。同時，海關合規要求也要求更詳細的產品編碼和文件記錄，這延長了關鍵產品的前置作業時間，並加重了供應商和買家的行政負擔。

揭示一個多軸細分框架，該框架將產品類型、應用、技術、工作流程階段和最終用戶概況與策略產品和商業化選擇聯繫起來。

一致的市場細分框架揭示了樣本製備領域的多面性，並明確了創新和需求的集中方向。從產品類型來看，市場涵蓋擴增試劑盒、片段化和大小分選解決方案、樣品製備盒以及標靶富集試劑盒。擴增試劑盒包括傳統的PCR方法，以及數位PCR和qPCR的各種變體，還包括使用鎖式探針的滾環擴增和基於phi29的方法。片段化和大小分選策略分為酵素片段化（內切酶和轉座子方法）和機械片段化方法，例如常用的超音波平台。樣品製備產品包括RNA特異性工作流程（包括mRNA、小RNA和總RNA試劑盒）、針對遺傳疾病和腫瘤基因panel的標靶文庫建構方法，以及從無PCR到標準全基因組定序（WGS）建構的各種全基因組文庫建構試劑盒。靶向序列捕獲遵循一條分岔的路徑，包括基於擴增子的方法（包括多重和單重 PCR）以及利用基於陣列或基於溶液形式的雜合反應捕獲策略。

本研究探討了區域供應鏈結構、管理體制和最終用戶知識水準如何影響技術採納、支援模式和商業化策略。

區域趨勢對樣本製備技術的應用、監管和商業化具有決定性影響。在美洲，強大的學術研究能力和密集分佈的診斷檢查室網路推動了對高通量自動化技術和支援臨床檢驗的專用試劑盒的需求。對轉化研究的投入以及成熟的私人生物技術產業促使供應商提供整合解決方案，以簡化監管申報和檢查室認證流程。此外，接近性主要製造商和區域分銷中心通常可以縮短前置作業時間並提升售後服務。

對整個供應商產業的競爭差異化因素進行評估，包括獨特的化學技術、與自動化的兼容性、服務模式和策略夥伴關係。

樣品製備領域的競爭格局體現了先進技術能力、廣泛檢驗的工作流程以及貫穿生命週期的客戶支援之間的平衡。主要企業憑藉其專有的化學技術脫穎而出，這些技術能夠降低變異性並加速檢驗，同時還能與自動化系統整合，並品管解決方案。試劑供應商和儀器製造商之間的合作日益普遍，從而創造出捆綁式解決方案，簡化了高通量臨床和商業定序實驗室的採購流程。同時，小規模的專業公司則專注於小眾化學技術，例如針對低起始量或受損DNA最佳化的酵素製劑，或能夠實現獨特樣品處理功能的微流體系統。

針對採購、定序和實驗室負責人的具體行動，以增強供應韌性、加快驗證速度並最佳化定序工作流程中的技術應用。

負責定序和樣品製備的人員必須採取務實且多層次的策略，使技術選擇與營運彈性和科學目標保持一致。首先，採購團隊應將供應鏈透明度、區域庫存能力和已記錄的緊急時應對計畫納入供應商選擇標準，從而減少對單一供應商的依賴，並最大限度地減少對驗證工作的干擾。同時，研發和實驗室管理人員應優先驗證模組化工作流程，並儘可能選擇組件級等效性檢驗，以便在不影響資料品質的前提下加快引入替代供應商。

為了得出可靠的結論，我們描述了一種混合方法研究途徑，該方法整合了相關人員訪談、技術文獻整合以及交叉檢驗的產品和工作流程映射。

本分析的研究途徑結合了結構化的原始研究、針對性的二手資訊整合以及嚴格的交叉檢驗。原始資料收集包括對學術界、臨床界和商業領域的實驗室管理人員、採購負責人和技術負責人進行詳細訪談，以了解營運限制、驗證實踐和技術偏好。這些訪談旨在揭示處理能力、靈敏度和人工時間之間的實際權衡，並確定應對供應鏈中斷的可行緩解策略。

由此可見，將樣品製備視為一項戰略能力對於確保數據完整性、營運韌性和永續的科學進步至關重要。

總之，次世代定序的樣品製備已從一系列獨立的實驗室任務發展成為一個策略性領域，對定序速度、可重複性和結果可解釋性有顯著影響。酵素化學、片段化策略、微流體和自動化等領域的技術進步，不僅拓展了可進行高品質定序的檢體類型，也使實驗室能夠在降低變異性的同時擴大操作規模。同時，貿易政策的變化和區域情況的演變，凸顯了多元化供應鏈、區域支持和供應商透明度在營運中的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：NGS樣品製備市場：依產品類型分類

  • 放大套件
    • PCR試劑盒
      • 常規PCR試劑盒
      • 數位PCR試劑盒
      • qPCR試劑盒
    • 滾動循環放大
      • 掛鎖探針底座
      • Phi29 基體
  • 碎片化和尺寸分選
    • 酵素裂解
      • 核酸內切酶鹼基
      • 轉置法
    • 機械破碎
      • Bioruptor
      • Covaris
  • 樣品製備工具包
    • RNA文庫製備
      • 軍用裝備
      • 小RNA試劑盒
      • 總RNA試劑盒
    • 標靶樣品製備
      • 遺傳疾病檢測
      • 腫瘤專家組
    • 全基因組樣品製備
      • 無需PCR的試劑盒
      • 標準WGS試劑盒
  • 目標濃度試劑盒
    • 放大器濃縮液
      • 多重PCR
      • 單重PCR
    • 雜合反應捕獲
      • 基於數組
      • 基於解決方案

第9章 NGS樣品製備市場：依技術分類

  • 以微珠為基礎
    • 磁珠
    • 固相珠
  • 基於酵素的
    • 紗布
    • 限制性內切酶
    • 轉置
  • 微流體技術
    • 基於液滴的
    • 晶片實驗室
  • 基於PCR的
    • 常規PCR
    • 數位PCR
    • qPCR

第10章：NGS樣品製備市場工作流程（依階段分類）

  • 放大
    • PCR擴增
    • 滾動圓圈
  • 豐富
    • 擴增子
    • 雜合反應
  • 碎片化
    • 酵素法
    • 機械的
  • 樣品製備
    • RNA製備
    • 針對性準備
    • 全基因組定序 (WGS) 製備
  • 定量分析和品管
    • 電泳
    • 螢光測量

第11章 NGS 樣品製備市場：依應用領域分類

  • 表觀遺傳學
    • 亞硫酸氫鹽序列
    • 晶片序列
  • 總體基因體學
    • 16S rRNA定序
    • 霰彈槍總體基因體學
  • RNA定序
    • miRNA定序
    • mRNA定序
    • 總RNA定序
  • 目標序列
    • 遺傳性疾病
    • 腫瘤學
    • 藥物基因體學
  • 全基因組定序

第12章 NGS 樣品製備市場：依最終用戶分類

  • 學術機構及政府機構
  • 合約研究機構
  • 診斷檢測實驗室
  • 製藥和生物技術

第13章 NGS 樣品製備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 NGS 樣品製備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 NGS 樣品製備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國NGS樣品製備市場

第17章：中國NGS樣品製備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • Applied Biological Materials Inc.
  • Aurora Biomed Inc.
  • Beckman Coulter by Danaher Corporation
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • BioDynami
  • Eppendorf SE
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche Ltd.
  • FORMULATRIX, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Macrogen Inc.
  • Magen Biotechnology Co., Ltd.
  • MCLAB
  • Merck KGaA
  • New England Biolabs, Inc.
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • PerkinElmer Inc.
  • Promega Corporation
  • Psomagen, Inc.
  • Qiagen NV
  • Standard BioTools Inc.
  • Sysmex Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Zymo Research Corporation
Product Code: MRR-9F52358C4167

The NGS Sample Preparation Market was valued at USD 3.24 billion in 2025 and is projected to grow to USD 3.72 billion in 2026, with a CAGR of 16.52%, reaching USD 9.45 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.24 billion
Estimated Year [2026] USD 3.72 billion
Forecast Year [2032] USD 9.45 billion
CAGR (%) 16.52%

Establishing why optimized sample preparation for next-generation sequencing is a strategic capability that drives data quality, workflow efficiency, and competitive differentiation

Next-generation sequencing sample preparation is the foundational discipline that determines data integrity, turnaround speed, and downstream analytical fidelity across research, clinical, and industrial applications. Over the past decade, incremental improvements in reagents, workflows, and automation have steadily compressed cycle times while expanding the range of applications from targeted panels to whole-genome and metagenomic assays. In this context, sample preparation is no longer a routine upstream task; it is a strategic capability that can materially influence overall throughput, reproducibility, and the cost-efficiency of sequencing programs.

Consequently, laboratories and organizations that invest deliberately in optimized sample preparation protocols-spanning fragmentation, amplification, library preparation, enrichment, and quantification-realize disproportionate gains in data quality and operational resilience. As sequencing platforms continue to diversify and customers demand higher sensitivity and lower input requirements, the role of sample preparation vendors, integrators, and internal process owners gains prominence. This introduction frames the subsequent analysis by emphasizing that strategic choices in reagents, hardware, and workflow design directly shape scientific outcomes and commercial competitiveness.

Explaining the technological, operational, and application-driven shifts that are reshaping sample preparation workflows and supplier priorities across laboratories

The landscape of sample preparation for next-generation sequencing is undergoing several transformative shifts driven by technological innovation, changing end-user demands, and evolving regulatory expectations. Advances in enzyme engineering and chemistry have enabled fragmentation and library-preparation chemistries that work reliably with lower-input, degraded, and archival samples, while microfluidics and droplet-based approaches have brought miniaturization and parallelization to routine workflows. These technological shifts are complemented by a rising emphasis on automation and closed-system solutions that reduce operator variability and accelerate time-to-result, particularly for clinical laboratories seeking to scale diagnostic throughput.

At the same time, the application spectrum is broadening: RNA sequencing applications are moving beyond bulk mRNA profiling into small RNA and total RNA characterization, and targeted enrichment methods are increasingly tailored for oncology, inherited-disease panels, and pharmacogenomics. Epigenetics and metagenomics workflows are benefiting from specialized conversion chemistries and library strategies that preserve biological signal while minimizing artifacts. Moreover, the competitive dynamics among suppliers are shifting as companies prioritize integrated workflow compatibility, service models, and reagent quality assurance. Collectively, these trends are reshaping procurement priorities and accelerating the adoption of modular solutions that can be validated quickly and scaled across heterogeneous lab environments. As a result, organizations must reassess vendor selection criteria, validation timelines, and internal capabilities to capture the benefits of these advances.

Analyzing how US tariff changes and trade policy adjustments in 2025 have increased supply chain friction, procurement complexity, and the prioritization of regional resilience

The cumulative effect of tariff actions and trade policy adjustments in the United States during 2025 has introduced new frictions into global supply chains for sample preparation reagents, plastics, and instrumentation. Elevated import duties and tightened classification requirements have increased landed costs for some hardware components and specialty consumables, prompting procurement teams to revisit supplier diversification, inventory policies, and contractual terms. In parallel, customs compliance has required more granular product coding and documentation, extending lead times for critical items while increasing administrative overhead for both vendors and buyers.

These developments have amplified the operational importance of local distribution partnerships, regional manufacturing footprints, and multi-sourcing strategies. Organizations have responded by prioritizing vendors that maintain regional inventory buffers or that have established manufacturing capacity closer to end markets. In some cases, laboratories have adjusted inventory and ordering cadence to accommodate longer and more volatile lead times, while validation teams have expanded their list of approved equivalencies to reduce single-source risk. Additionally, price negotiation has increasingly factored in total landed cost, including duties and customs-processing expenses, rather than relying solely on list prices.

From a strategic perspective, the tariff-driven environment has accelerated initiatives to simplify supply chains: vendors are consolidating SKUs, offering bundled kits to reduce cross-border transactions, and investing in local service capabilities. For buyers, the imperative is clear-adapt procurement strategies to emphasize supply continuity, contractual flexibility, and vendor transparency. Taken together, these shifts affect capital planning, validation scheduling, and cost-per-assay calculations, and they underscore the importance of supply chain resilience as an integral component of long-term operational planning.

Unpacking a multi-axis segmentation framework that links product types, applications, technologies, workflow steps, and end-user profiles to strategic product and commercialization choices

A coherent segmentation framework reveals the multidimensional nature of the sample preparation landscape and clarifies where innovation and demand are concentrated. When viewed through the lens of product type, the market spans amplification kits, fragmentation and size selection solutions, library preparation kits, and target enrichment kits. Amplification kits encompass conventional PCR approaches as well as digital PCR and qPCR variants, and further include rolling circle amplification with padlock probe and phi29-based methods. Fragmentation and size selection strategies divide into enzymatic fragmentation-distinguishing endonuclease and transposase approaches-and mechanical fragmentation methods such as popular sonication platforms. Library preparation offerings cover RNA-focused workflows (including mRNA, small RNA, and total RNA kits), targeted library approaches for inherited disease and oncology panels, and whole-genome library kits that range from PCR-free to standard WGS preparations. Target enrichment follows a bifurcated path of amplicon-based methods, including multiplex and singleplex PCR, and hybridization-capture strategies that may leverage either array-based or solution-based formats.

Examining segmentation by application further sharpens strategic focus: epigenetics workflows employ bisulfite and ChIP sequencing techniques to interrogate regulatory marks, metagenomics relies on 16S rRNA sequencing and shotgun approaches to profile complex microbial communities, and RNA sequencing spans miRNA, mRNA, and total RNA modalities. Targeted sequencing use-cases emphasize inherited disease, oncology, and pharmacogenomics, reflecting clinical and translational priorities that demand high sensitivity and rigorous validation. Technology segmentation highlights bead-based and enzyme-based chemistries, microfluidic platforms that include droplet and lab-on-chip implementations, and PCR-centric technologies that appear across conventional, digital, and qPCR formats. Finally, evaluating the workflow step perspective clarifies where value is added: amplification, enrichment, fragmentation, library construction, and quantification/quality control each present distinct performance and validation challenges, with quantification increasingly relying on electrophoretic and fluorometric methods. End-user segmentation identifies academic and government research institutions, contract research organizations, diagnostic laboratories, and pharmaceutical and biotechnology companies as the primary adopters, each with different throughput, validation, and procurement requirements.

Taken together, these segmentation layers provide a granular map for product development, go-to-market strategies, and service offerings. They reveal opportunities for suppliers to specialize vertically-for example, by focusing on low-input RNA library chemistry for clinical diagnostics-or to offer modular, validated bundles that reduce buyer validation burden across common workflow steps. This multi-axis view also supports more nuanced commercial conversations with end users, where the intersection of product type, application, and workflow step determines evaluation criteria and procurement timelines.

Exploring how regional supply chain architecture, regulatory regimes, and end-user sophistication shape adoption, support models, and commercialization strategies

Regional dynamics exert a decisive influence on how sample preparation technologies are adopted, regulated, and commercialized. In the Americas, strong academic research capacity and a dense concentration of diagnostic laboratory networks drive demand for both high-throughput automation and specialized kits that support clinical validation. Investment in translational research and a mature private biotech sector incentivize suppliers to provide integrated solutions that ease regulatory submission and laboratory accreditation. In addition, proximity to major manufacturers and regional distribution hubs often shortens lead times and improves after-sales support.

Europe, the Middle East, and Africa display heterogenous adoption patterns driven by differing regulatory regimes, funding models, and healthcare priorities. Western European markets prioritize compliance, reproducibility, and integration with national health systems, motivating suppliers to demonstrate robust quality systems and CE marking or equivalent certifications. Meanwhile, markets across the Middle East and Africa may prioritize cost-effective, ruggedized solutions and localized training and service models. These regional distinctions create opportunities for differentiated go-to-market strategies that account for regulatory complexity, procurement cycles, and local laboratory capacity.

The Asia-Pacific region combines dynamic growth in research infrastructure with rapidly expanding clinical genomics initiatives. Investments in domestic manufacturing and reagent production are notable, driving a mix of locally developed solutions and international partnerships. Differences in regulatory frameworks across countries, varying reimbursement policies, and diverse end-user needs mean that suppliers who can offer adaptable product platforms and local technical support are particularly well-positioned. Across all regions, the overarching theme is that regional supply chain architecture, regulatory expectations, and end-user sophistication jointly shape adoption curves and the design of commercially viable offerings.

Assessing competitive differentiation driven by proprietary chemistries, automation compatibility, service models, and strategic partnerships across the supplier landscape

Competitive dynamics among companies active in sample preparation reflect a balance between deep technical capability, breadth of validated workflows, and the ability to support customers through lifecycle services. Key players differentiate themselves through proprietary chemistries, automation integrations, and quality-control solutions that reduce variability and accelerate validation. Partnerships between reagent providers and instrument manufacturers are increasingly common, yielding bundled solutions that simplify procurement for high-throughput clinical and commercial sequencing labs. At the same time, smaller specialist firms focus on niche chemistries-such as enzyme formulations optimized for low-input or damaged DNA-or on microfluidic systems that enable unique sample handling capabilities.

Investment patterns highlight that companies concentrating on interoperability and open-architecture models can gain traction in environments where buyers prioritize flexibility and vendor neutrality. Conversely, firms that develop closed, fully validated systems appeal to clinical adopters seeking minimal hands-on validation and predictable performance. A further competitive axis centers on service and training: organizations offering on-site method transfer, validation support, and rapid reagent replacement tend to retain higher customer loyalty. Mergers, strategic alliances, and licensing agreements are likely to persist as routes to expand product portfolios and distribution reach, while R&D emphasis on enzyme innovation, low-bias library chemistries, and on-deck automation continues to define technology leadership. In this environment, commercial success depends on a mix of technical excellence, regulatory readiness, and a service-oriented approach that addresses customers' operational constraints.

Prescriptive actions for procurement, R&D, and laboratory leaders to enhance supply resilience, accelerate validation, and optimize technology adoption for sequencing workflows

Leaders in sequencing and sample preparation must adopt a pragmatic, layered strategy that aligns technology choices with operational resilience and scientific objectives. First, procurement teams should expand vendor qualification criteria to include supply chain transparency, regional inventory capabilities, and documented contingency plans, thereby reducing single-source exposure and minimizing validation disruptions. Concurrently, R&D and laboratory directors should prioritize modular workflow validation-opting for component-level equivalency testing where feasible-to accelerate adoption of alternative suppliers without compromising data quality.

Second, invest selectively in automation and closed-system solutions for high-throughput and clinical operations while retaining manual or bench-top flexibility for exploratory and low-volume studies. This hybrid approach balances the throughput and reproducibility gains of automation with the experimental agility needed for method development. Third, cultivate deeper technical partnerships with suppliers that provide co-validation support, method transfer services, and joint training programs; these relationships shorten qualification timelines and improve run-to-run consistency. Fourth, incorporate total landed cost into procurement decision-making, including considerations of tariffs, customs processing, and regional service availability, to ensure commercial decisions reflect operational realities. Finally, create a governance cadence that aligns procurement, compliance, and scientific leadership around validation timelines, change control processes, and inventory policies. Together, these actions enable organizations to maintain scientific rigor, reduce operational risk, and accelerate time-to-insight.

Describing a mixed-methods research approach that integrates stakeholder interviews, technical literature synthesis, and cross-validated product and workflow mapping to ensure robust conclusions

The research approach underpinning this analysis combined structured primary engagement with targeted secondary-source synthesis and rigorous cross-validation. Primary data collection included in-depth interviews with laboratory directors, procurement officers, and technical leads across academic, clinical, and commercial settings to capture operational constraints, validation practices, and technology preferences. These interviews were designed to surface real-world trade-offs between throughput, sensitivity, and hands-on time, and to identify practical mitigation strategies for supply chain disruptions.

Secondary research encompassed technical literature, regulatory guidance, vendor documentation, and publicly available product specifications to map technology features and workflow compatibility. Where possible, product performance characteristics were triangulated across multiple sources to reduce reliance on single-provider claims. The analysis also incorporated case studies of workflow implementations and procurement adaptations to highlight replicable best practices. Data synthesis employed thematic coding to distill recurring challenges and opportunities, and cross-sectional matrices were used to align segmentation layers with end-user requirements.

Limitations are acknowledged: proprietary performance data and unpublished validation studies were not available for all products, and some supplier-specific operational details remain confidential. Nonetheless, the methodology emphasizes reproducibility and transparency, prioritizing observable practices and verifiable documentation while situating findings within broader technological and regulatory trends.

Summarizing why treating sample preparation as a strategic capability is essential for ensuring data integrity, operational resilience, and sustained scientific advancement

In conclusion, sample preparation for next-generation sequencing has evolved from a set of discrete laboratory tasks into a strategic domain that materially affects speed, reproducibility, and the interpretability of sequencing results. Technological advances in enzyme chemistry, fragmentation strategies, microfluidics, and automation are expanding the types of specimens amenable to high-quality sequencing while enabling laboratories to scale operations with reduced variability. Concurrently, trade policy shifts and evolving regional dynamics underscore the operational need for diversified supply chains, regional support, and vendor transparency.

Organizations that proactively align procurement, validation, and scientific strategy will be best positioned to capture the benefits of emerging technologies. Prioritizing multi-sourcing, modular validation, and strategic supplier partnerships can mitigate supply chain risk while preserving scientific flexibility. Ultimately, leaders who treat sample preparation as an integral element of their sequencing strategy-rather than a peripheral commodity-will realize better data quality, faster turnaround, and more reliable outcomes across research and clinical programs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. NGS Sample Preparation Market, by Product Type

  • 8.1. Amplification Kits
    • 8.1.1. Pcr Kits
      • 8.1.1.1. Conventional Pcr Kits
      • 8.1.1.2. Digital Pcr Kits
      • 8.1.1.3. Qpcr Kits
    • 8.1.2. Rolling Circle Amplification
      • 8.1.2.1. Padlock Probe Based
      • 8.1.2.2. Phi29 Based
  • 8.2. Fragmentation And Size Selection
    • 8.2.1. Enzymatic Fragmentation
      • 8.2.1.1. Endonuclease Based
      • 8.2.1.2. Transposase Based
    • 8.2.2. Mechanical Fragmentation
      • 8.2.2.1. Bioruptor
      • 8.2.2.2. Covaris
  • 8.3. Library Prep Kits
    • 8.3.1. Rna Library Prep
      • 8.3.1.1. Mrna Kits
      • 8.3.1.2. Small Rna Kits
      • 8.3.1.3. Total Rna Kits
    • 8.3.2. Targeted Library Prep
      • 8.3.2.1. Inherited Disease Panels
      • 8.3.2.2. Oncology Panels
    • 8.3.3. Whole Genome Library Prep
      • 8.3.3.1. Pcr-free Kits
      • 8.3.3.2. Standard Wgs Kits
  • 8.4. Target Enrichment Kits
    • 8.4.1. Amplicon Enrichment
      • 8.4.1.1. Multiplex Pcr
      • 8.4.1.2. Singleplex Pcr
    • 8.4.2. Hybridization Capture
      • 8.4.2.1. Array Based
      • 8.4.2.2. Solution Based

9. NGS Sample Preparation Market, by Technology

  • 9.1. Bead Based
    • 9.1.1. Magnetic Beads
    • 9.1.2. Solid Phase Beads
  • 9.2. Enzyme Based
    • 9.2.1. Ligase
    • 9.2.2. Restriction Enzyme
    • 9.2.3. Transposase
  • 9.3. Microfluidics
    • 9.3.1. Droplet Based
    • 9.3.2. Lab On Chip
  • 9.4. Pcr Based
    • 9.4.1. Conventional Pcr
    • 9.4.2. Digital Pcr
    • 9.4.3. Qpcr

10. NGS Sample Preparation Market, by Workflow Step

  • 10.1. Amplification
    • 10.1.1. Pcr Amplification
    • 10.1.2. Rolling Circle
  • 10.2. Enrichment
    • 10.2.1. Amplicon
    • 10.2.2. Hybridization
  • 10.3. Fragmentation
    • 10.3.1. Enzymatic
    • 10.3.2. Mechanical
  • 10.4. Library Preparation
    • 10.4.1. Rna Prep
    • 10.4.2. Targeted Prep
    • 10.4.3. Wgs Prep
  • 10.5. Quantification And QC
    • 10.5.1. Electrophoretic
    • 10.5.2. Fluorometric

11. NGS Sample Preparation Market, by Application

  • 11.1. Epigenetics
    • 11.1.1. Bisulfite Sequencing
    • 11.1.2. Chip Sequencing
  • 11.2. Metagenomics
    • 11.2.1. 16s Rrna Sequencing
    • 11.2.2. Shotgun Metagenomics
  • 11.3. Rna Sequencing
    • 11.3.1. Mirna Sequencing
    • 11.3.2. Mrna Sequencing
    • 11.3.3. Total Rna Sequencing
  • 11.4. Targeted Sequencing
    • 11.4.1. Inherited Disease
    • 11.4.2. Oncology
    • 11.4.3. Pharmacogenomics
  • 11.5. Whole Genome Sequencing

12. NGS Sample Preparation Market, by End User

  • 12.1. Academic And Government
  • 12.2. Contract Research Organizations
  • 12.3. Diagnostic Laboratories
  • 12.4. Pharma And Biotech

13. NGS Sample Preparation Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. NGS Sample Preparation Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. NGS Sample Preparation Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States NGS Sample Preparation Market

17. China NGS Sample Preparation Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc.
  • 18.6. Applied Biological Materials Inc.
  • 18.7. Aurora Biomed Inc.
  • 18.8. Beckman Coulter by Danaher Corporation
  • 18.9. BGI Group
  • 18.10. Bio-Rad Laboratories, Inc.
  • 18.11. BioDynami
  • 18.12. Eppendorf SE
  • 18.13. Eurofins Genomics LLC
  • 18.14. F. Hoffmann-La Roche Ltd.
  • 18.15. FORMULATRIX, Inc.
  • 18.16. Illumina, Inc.
  • 18.17. Integrated DNA Technologies, Inc.
  • 18.18. Macrogen Inc.
  • 18.19. Magen Biotechnology Co., Ltd.
  • 18.20. MCLAB
  • 18.21. Merck KGaA
  • 18.22. New England Biolabs, Inc.
  • 18.23. Novogene Co., Ltd.
  • 18.24. Oxford Nanopore Technologies PLC
  • 18.25. PerkinElmer Inc.
  • 18.26. Promega Corporation
  • 18.27. Psomagen, Inc.
  • 18.28. Qiagen N.V.
  • 18.29. Standard BioTools Inc.
  • 18.30. Sysmex Corporation
  • 18.31. Takara Bio Inc.
  • 18.32. Thermo Fisher Scientific Inc.
  • 18.33. Twist Bioscience Corporation
  • 18.34. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NGS SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NGS SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW STEP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NGS SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BEAD BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BEAD BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BEAD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLID PHASE BEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLID PHASE BEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLID PHASE BEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYME BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYME BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYME BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYME BASED, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIGASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIGASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIGASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RESTRICTION ENZYME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RESTRICTION ENZYME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RESTRICTION ENZYME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DROPLET BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DROPLET BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DROPLET BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LAB ON CHIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LAB ON CHIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LAB ON CHIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR BASED, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW STEP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENRICHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENRICHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENRICHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENRICHMENT, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA PREP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA PREP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA PREP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED PREP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED PREP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED PREP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WGS PREP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WGS PREP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WGS PREP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QUANTIFICATION AND QC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QUANTIFICATION AND QC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QUANTIFICATION AND QC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QUANTIFICATION AND QC, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ELECTROPHORETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ELECTROPHORETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ELECTROPHORETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FLUOROMETRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FLUOROMETRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FLUOROMETRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 259. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHARMACOGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 262. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 265. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC AND GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 268. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC AND GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC AND GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 271. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 274. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 275. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHARMA AND BIOTECH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 277. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHARMA AND BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 278. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHARMA AND BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 280. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 281. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, 2018-2032 (USD MILLION)
  • TABLE 283. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, 2018-2032 (USD MILLION)
  • TABLE 284. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 285. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, 2018-2032 (USD MILLION)
  • TABLE 286. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 287. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 288. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, 2018-2032 (USD MILLION)
  • TABLE 289. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, 2018-2032 (USD MILLION)
  • TABLE 290. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, 2018-2032 (USD MILLION)
  • TABLE 291. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, 2018-2032 (USD MILLION)
  • TABLE 292. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, 2018-2032 (USD MILLION)
  • TABLE 293. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, 2018-2032 (USD MILLION)
  • TABLE 294. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, 2018-2032 (USD MILLION)
  • TABLE 295. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 296. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 297. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYME BASED, 2018-2032 (USD MILLION)
  • TABLE 298. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 299. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY PCR BASED, 2018-2032 (USD MILLION)
  • TABLE 300. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW STEP, 2018-2032 (USD MILLION)
  • TABLE 301. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 302. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY ENRICHMENT, 2018-2032 (USD MILLION)
  • TABLE 303. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 304. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 305. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY QUANTIFICATION AND QC, 2018-2032 (USD MILLION)
  • TABLE 306. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE,